DrugPatentWatch Database Preview
Drugs in Development Information for Salvinorin A
» See Plans and Pricing
What is the development status for investigational drug Salvinorin A?
Salvinorin A is an investigational drug.
There have been 4 clinical trials for Salvinorin A.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 14th 2017.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Johns Hopkins University, National Alliance for Research on Schizophrenia and Depression, and California Pacific Medical Center Research Institute.
There are one hundred US patents protecting this investigational drug and four hundred and forty-three international patents.
Summary for Salvinorin A
| US Patents | 100 |
| International Patents | 443 |
| US Patent Applications | 214 |
| WIPO Patent Applications | 373 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2017-12-14) |
| Vendors | 18 |
Recent Clinical Trials for Salvinorin A
| Title | Sponsor | Phase |
|---|---|---|
| Effects of Salvinorin A on Brain Function | Johns Hopkins University | Phase 1/Phase 2 |
| Placebo Controlled Study of Sublingual Salvinorin A | California Pacific Medical Center Research Institute | N/A |
| Effects of Salvinorin A in Healthy Controls | National Alliance for Research on Schizophrenia and Depression | Phase 1 |
Clinical Trial Summary for Salvinorin A
Top disease conditions for Salvinorin A
Top clinical trial sponsors for Salvinorin A
US Patents for Salvinorin A
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Salvinorin A | Start Trial | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | Start Trial | |
| Salvinorin A | Start Trial | Pharmaceutical composition and method of manufacturing | CURE PHARMACEUTICAL HOLDING CORP. (Oxnard, CA) | Start Trial |
| Salvinorin A | Start Trial | Pharmaceutical compositions resistant to abuse | EGALET LTD. (London, GB) | Start Trial |
| Salvinorin A | Start Trial | Multifunctional aminoquinoline therapeutic agents | LOHOCLA RESEARCH CORPORATION (Evanston, IL) | Start Trial |
| Salvinorin A | Start Trial | Methods, devices and systems for pulmonary delivery of active agents | Syqe Medical Ltd. (Tel-Aviv, IL) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Salvinorin A
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Salvinorin A | European Patent Office | EP3324975 | 2035-07-22 | Start Trial |
| Salvinorin A | World Intellectual Property Organization (WIPO) | WO2017015309 | 2035-07-22 | Start Trial |
| Salvinorin A | World Intellectual Property Organization (WIPO) | WO2019236121 | 2035-07-22 | Start Trial |
| Salvinorin A | Australia | AU2010211376 | 2029-02-06 | Start Trial |
| Salvinorin A | Australia | AU2013257533 | 2029-02-06 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
